January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

In a move that the company, said demonstrates its commitment to investing in higher growth areas, Zimmer Biomet Holdings Inc. reported its plans to buy foot and ankle (F&A) orthopedic specialist ...

BioWorld’s three-part analysis of M&As sought to discover successful transactions and to understand the trend of multibillion-dollar deals that have become commonplace in the last decade. Instead, ...

Shares of Denmark’s Novo Nordisk (NOV: N) rose 3.5% to 613.30 kroner this morning, after the company reported better-than-expected net profit amid soaring demand for its Wegovy (semaglutide) obesity ...

After hours: 7:59:22 p.m. EST Loading Chart for NVO ...

After hours: 7:59:50 pm GMT-5 Loading Chart for NVO ...

After hours: 7:59:44 pm GMT-5 ...